RxDoctor Payments Data

Kevin Miller, DPM

Foot & Ankle Surgery · Fairfield, CANPI 1982851549

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (48.8%), travel and lodging and other — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Stryker at 36.8% of the total. 2025 is the largest year on record at $2,062, 2.1 times the $980 reported in 2019.

$5,641in general payments, 2019–2025

Across 75 payments — averaging $75.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$2K
  • Valencia Technologies Corporation$1K
  • Integra Lifesciences Corporation$816
  • Tenex Health Inc.$264
  • Johnson & Johnson$217
  • Biotissue Holdings Inc.$176
  • plus $602 from 10 others
$24,491in research payments, 2019–2025

Across 6 payments — averaging $4081.83 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Biotissue Holdings Inc.$24K

What the payments were for

  • Travel & lodging$2,12238%
  • Food & beverage$2,75449%
  • Other$76514%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,641 in reported general payments places this provider in the 75th percentile of 1,126 foot & ankle surgery providers in California.

See all foot & ankle surgery providers in California

Medicare billing

Part B allowed, 2024
$332,157
Medicare patients
534
Services billed
3,374

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clotrimazole53$2,309
Gabapentin64$2,038
Pregabalin26$1,331
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen23$311
Clindamycin Hcl14$241
Levofloxacin16$205
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen14$96

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Fairfield

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →